The following slide kit outlines the principles and steps for somatostatin receptor-based imaging, specifically in managing neuroendocrine tumors.

Learn about the concept of theranostics in oncology and how radiopharmaceuticals, diagnostic and therapeutic compounds labeled with radionuclides, play a central role in this approach.​

Somatostatin signaling is an important pathway involved in the pathophysiology of neuroendocrine tumors (NETs) that allows a personalized theranostic approach to their management.